by Hayden Roberts | Mar 7, 2024
Beginning a multi-year investment in research funding, which has since yielded the identification of immunotherapeutic targets and led to a clinical trial testing an existing immunotherapy against esophageal cancer at Dana-Farber Cancer Institute.
by Hayden Roberts | Mar 7, 2024
Through a research grant to the Bass lab at the Dana-Farber Cancer Institute aimed at improving understanding and treatment for this under-resourced, fast-growing rare cancer.
by Hayden Roberts | Mar 7, 2024
At Massachusetts General Hospital, leading to a first-of-its-kind cholangiocarcinoma cell line collection which was completed in 2019 and later moved into the public domain. We also hosted the first Cholangiocarcinoma Think Tank meeting this year, laying the...
by Hayden Roberts | Mar 7, 2024
To the Bardeesy Lab at the Massachusetts General Hospital Cancer Center, aimed at generating the basic research tools needed to understand drivers and expand treatment options for this rare cancer.
by Hayden Roberts | Mar 7, 2024
Uniting hundreds of patients, caregivers, doctors, researchers, and advocacy partners to raise awareness and funds for rare cancer research and patient support.
